Log In
Print
BCIQ
Print
Print this Print this
 

Mycapssa, octreotide (RG3806) (formerly Octreolin)

  Manage Alerts
Collapse Summary General Information
Company Chiasma Inc.
DescriptionOral formulation of octreotide acetate, a somatostatin analog, using Transient Permeability Enhancer technology
Molecular Target Growth hormone receptor
Mechanism of ActionGrowth hormone receptor antagonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$595.0M

$65.0M

$530.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today